The Ohio State University Wexner Medical Center East Hospital is a university hospital in King-Lincoln Bronzeville, Columbus, Ohio. The hospital has a Level III trauma center, an emergency department, and provides numerous inpatient and outpatient services.

There are 190 beds in The Ohio State University Hospital East.

During the past decade, The Ohio State University Hospital East conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Ohio State University Hospital East" #1 sponsor was "Pfizer" with 3 trials, followed by "Gayle Gordillo" with 1 trials sponsored, "HealthCore-NERI" with 1 trials sponsored, "Johns Hopkins University" with 1 trials sponsored and "Ohio State University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Ohio State University Hospital East" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Nationwide Children's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Ohio State University Hospital East" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "ACE Inhibitor Induced Angioedema" (1 trials), "Advanced Cancer" (1 trials), "Angina" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "The Ohio State University Hospital East" in a lesser frequency.

Most popular intervention types in "The Ohio State University Hospital East" are "Drug" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "PF-02341066" (2 trials), "Docetaxel" (1 trials), "Pemetrexed" (1 trials), "Placebo" (1 trials) and "Procellera" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Ohio State University Hospital East" are 9 trials for "All" genders.

Currently, there are NaN active trials in "The Ohio State University Hospital East". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in The Ohio State University Hospital East, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Ohio State University Hospital East, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".